Ethyl 8-bromo-2-methylquinoline-3-carboxylate

Catalog No.: 
ACVWMJ730
CAS No.: 
1333255-21-2
Molecular Formula: 
C13H12BrNO2
Molecular Weight: 
294.15
Ethyl 8-bromo-2-methylquinoline-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%
250mg95%
1g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 8-bromo-2-methylquinoline-3-carboxylate
IUPAC Nameethyl 8-bromo-2-methylquinoline-3-carboxylate
MDL No.MFCD20036315
Molecular FormulaC13H12BrNO2
Molecular Weight294.15
SMILESO=C(C1=CC2=CC=CC(Br)=C2N=C1C)OCC
InChI KeyTUMQMWIVAZEEMS-UHFFFAOYSA-N
Synonym3-Quinolinecarboxylic acid, 8-bromo-2-methyl-, ethyl ester
CAS No.1333255-21-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVWMJ730 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFXBH705 route compound structure diagram
    ACFXBH70514284-06-1In Stock
  2. Plus
  3. ACGHZN854 route compound structure diagram
    ACGHZN854145123-24-6In Stock
  4. Then
  5. ACVWMJ730 route product structure diagram
    ACVWMJ7301333255-21-2
Inquiry

2. ACVWMJ730 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVWMJ730 route product structure diagram
    ACVWMJ7301333255-21-2
Inquiry

3. ACVWMJ730 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVWMJ730 route product structure diagram
    ACVWMJ7301333255-21-2
Inquiry

Comments (0)